TOC - Ischemic Heart Disease (IHD) Drugs Market

Ischemic Heart Disease (IHD) Drugs Market Report by Disease Class (Angina Pectoris, Myocardial Infarction), Drug Class (Anti-Dyslipidemic Drugs, Calcium Channel Blockers, Beta-Blockers, ACE Inhibitors, ARBs, Vasodilators, Antithrombotic Agents), and Region 2025-2033

Report Format: PDF+Excel | Report ID: SR112025A1413

Buy Now

1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global Ischemic Heart Disease (IHD) Drugs Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 Market Breakup by Disease Class
6.1 Angina Pectoris
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Myocardial Infarction
6.2.1 Market Trends
6.2.2 Market Forecast
7 Market Breakup by Drug Class
7.1 Anti-Dyslipidemic Drugs
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Calcium Channel Blockers
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 Beta-Blockers
7.3.1 Market Trends
7.3.2 Market Forecast
7.4 ACE Inhibitors
7.4.1 Market Trends
7.4.2 Market Forecast
7.5 ARBs
7.5.1 Market Trends
7.5.2 Market Forecast
7.6 Vasodilators
7.6.1 Market Trends
7.6.2 Market Forecast
7.7 Antithrombotic Agents
7.7.1 Market Trends
7.7.2 Market Forecast
8 Market Breakup by Region
8.1 North America
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Europe
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Asia Pacific
8.3.1 Market Trends
8.3.2 Market Forecast
8.4 Middle East and Africa
8.4.1 Market Trends
8.4.2 Market Forecast
8.5 Latin America
8.5.1 Market Trends
8.5.2 Market Forecast
9 SWOT Analysis
9.1 Overview
9.2 Strengths
9.3 Weaknesses
9.4 Opportunities
9.5 Threats
10 Value Chain Analysis
11 Porters Five Forces Analysis
11.1 Overview
11.2 Bargaining Power of Buyers
11.3 Bargaining Power of Suppliers
11.4 Degree of Competition
11.5 Threat of New Entrants
11.6 Threat of Substitutes
12 Price Analysis
13 Competitive Landscape
13.1 Market Structure
13.2 Key Players
13.3 Profiles of Key Players
13.3.1 Bayer AG
13.3.2 Eli Lilly and Company
13.3.3 Novartis International AG
13.3.4 Pfizer, Inc.
13.3.5 Sanofi S.A.
13.3.6 Actelion Pharmaceuticals Ltd.
13.3.7 Baxter International Inc.
13.3.8 Boehringer Ingelheim International GmbH
13.3.9 Bristol-Myers Squibb Company
13.3.10 Amgen Inc.
13.3.11 F. Hoffmann-La Roche AG
13.3.12 GlaxoSmithKline Plc
13.3.13 Merck & Co.
13.3.14 Eisai Co., Ltd.

List of Figures

Figure 1: Global: Ischemic Heart Disease Drugs Market: Major Drivers and Challenges
Figure 2: Global: Ischemic Heart Disease Drugs Market: Sales Value (in Billion USD), 2019-2024
Figure 3: Global: Ischemic Heart Disease Drugs Market: Breakup by Disease Class (in %), 2024
Figure 4: Global: Ischemic Heart Disease Drugs Market: Breakup by Drug Class (in %), 2024
Figure 5: Global: Ischemic Heart Disease Drugs Market: Breakup by Region (in %), 2024
Figure 6: Global: Ischemic Heart Disease Drugs Market Forecast: Sales Value (in Billion USD), 2025-2033
Figure 7: Global: Ischemic Heart Disease Drugs (Angina Pectoris) Market: Sales Value (in Million USD), 2019 & 2024
Figure 8: Global: Ischemic Heart Disease Drugs (Angina Pectoris) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 9: Global: Ischemic Heart Disease Drugs (Myocardial Infarction) Market: Sales Value (in Million USD), 2019 & 2024
Figure 10: Global: Ischemic Heart Disease Drugs (Myocardial Infarction) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 11: Global: Ischemic Heart Disease Drugs (Anti-Dyslipidemic Drugs) Market: Sales Value (in Million USD), 2019 & 2024
Figure 12: Global: Ischemic Heart Disease Drugs (Anti-Dyslipidemic Drugs) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 13: Global: Ischemic Heart Disease Drugs (Calcium Channel Blockers) Market: Sales Value (in Million USD), 2019 & 2024
Figure 14: Global: Ischemic Heart Disease Drugs (Calcium Channel Blockers) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 15: Global: Ischemic Heart Disease Drugs (Beta-Blockers) Market: Sales Value (in Million USD), 2019 & 2024
Figure 16: Global: Ischemic Heart Disease Drugs (Beta-Blockers) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 17: Global: Ischemic Heart Disease Drugs (ACE Inhibitors) Market: Sales Value (in Million USD), 2019 & 2024
Figure 18: Global: Ischemic Heart Disease Drugs (ACE Inhibitors) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 19: Global: Ischemic Heart Disease Drugs (ARBs) Market: Sales Value (in Million USD), 2019 & 2024
Figure 20: Global: Ischemic Heart Disease Drugs (ARBs) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 21: Global: Ischemic Heart Disease Drugs (Vasodilators) Market: Sales Value (in Million USD), 2019 & 2024
Figure 22: Global: Ischemic Heart Disease Drugs (Vasodilators) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 23: Global: Ischemic Heart Disease Drugs (Antithrombotic Agents) Market: Sales Value (in Million USD), 2019 & 2024
Figure 24: Global: Ischemic Heart Disease Drugs (Antithrombotic Agents) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 25: North America: Ischemic Heart Disease Drugs Market: Sales Value (in Million USD), 2019 & 2024
Figure 26: North America: Ischemic Heart Disease Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 27: Europe: Ischemic Heart Disease Drugs Market: Sales Value (in Million USD), 2019 & 2024
Figure 28: Europe: Ischemic Heart Disease Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 29: Asia Pacific: Ischemic Heart Disease Drugs Market: Sales Value (in Million USD), 2019 & 2024
Figure 30: Asia Pacific: Ischemic Heart Disease Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 31: Middle East and Africa: Ischemic Heart Disease Drugs Market: Sales Value (in Million USD), 2019 & 2024
Figure 32: Middle East and Africa: Ischemic Heart Disease Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 33: Latin America: Ischemic Heart Disease Drugs Market: Sales Value (in Million USD), 2019 & 2024
Figure 34: Latin America: Ischemic Heart Disease Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 35: Global: Ischemic Heart Disease Drugs Industry: SWOT Analysis
Figure 36: Global: Ischemic Heart Disease Drugs Industry: Value Chain Analysis
Figure 37: Global: Ischemic Heart Disease Drugs Industry: Porter’s Five Forces Analysis

List of Tables

Table 1: Global: Ischemic Heart Disease Drugs Market: Key Industry Highlights, 2024 and 2033
Table 2: Global: Ischemic Heart Disease Drugs Market Forecast: Breakup by Disease Class (in Million USD), 2025-2033
Table 3: Global: Ischemic Heart Disease Drugs Market Forecast: Breakup by Drug Class (in Million USD), 2025-2033
Table 4: Global: Ischemic Heart Disease Drugs Market Forecast: Breakup by Region (in Million USD), 2025-2033
Table 5: Global: Ischemic Heart Disease Drugs Market: Competitive Structure
Table 6: Global: Ischemic Heart Disease Drugs Market: Key Players

Purchase Options New Year Sale

Inquire Before Buying

Speak to an Analyst

Request Brochure

Request Customization

Benefits of Customization

Personalize this research
Triangulate with your data
Get data as per your format and definition
Gain a deeper dive into a specific application, geography, customer, or competitor
Any level of personalization

Get in Touch With Us

UNITED STATES

Phone: +1-631-791-1145

INDIA

Phone: +91-120-433-0800

UNITED KINGDOM

Phone: +44-753-714-6104

Email: sales@imarcgroup.com

Client Testimonials

IMARC made the whole process easy. Everyone I spoke with via email was polite, easy to deal with, kept their promises regarding delivery timelines and were solutions focused. From my first contact, I was grateful for the professionalism shown by the whole IMARC team. I recommend IMARC to all that need timely, affordable information and advice. My experience with IMARC was excellent and I can not fault it.

The IMARC team was very reactive and flexible with regard to our requests. A very good overall experience. We are happy with the work that IMARC has provided, very complete and detailed. It has contributed to our business needs and provided the market visibility that we required

We were very happy with the collaboration between IMARC and Colruyt. Not only were your prices competitive, IMARC was also pretty fast in understanding the scope and our needs for this project. Even though it was not an easy task, performing a market research during the COVID-19 pandemic, you were able to get us the necessary information we needed. The IMARC team was very easy to work with and they showed us that it would go the extra mile if we needed anything extra

Last project executed by your team was as per our expectations. We also would like to associate for more assignments this year. Kudos to your team.

We would be happy to reach out to IMARC again, if we need Market Research/Consulting/Consumer Research or any associated service. Overall experience was good, and the data points were quite helpful.

Arabian Plastic Manufacturing Company Ltd.

The figures of market study were very close to our assumed figures. The presentation of the study was neat and easy to analyse. The requested details of the study were fulfilled. My overall experience with the IMARC Team was satisfactory.

The overall cost of the services were within our expectations. I was happy to have good communications in a timely manner. It was a great and quick way to have the information I needed.

My questions and concerns were answered in a satisfied way. The costs of the services were within our expectations. My overall experience with the IMARC Team was very good.

I agree the report was timely delivered, meeting the key objectives of the engagement. We had some discussion on the contents, adjustments were made fast and accurate. The response time was minimum in each case. Very good. You have a satisfied customer.

We would be happy to reach out to IMARC for more market reports in the future. The response from the account sales manager was very good. I appreciate the timely follow ups and post purchase support from the team. My overall experience with IMARC was good.

IMARC was a good solution for the data points that we really needed and couldn't find elsewhere. The team was easy to work, quick to respond, and flexible to our customization requests.

IMARC did an outstanding job in preparing our study. They were punctual and precise, delivering all the data we required in a clear and well-organized format. Their attention to detail and ability to meet deadlines was impressive, making them a reliable partner for our project.

I wanted to express my sincere appreciation for your efforts in handling this matter. Your dedication and commitment have truly been commendable. It is evident that you have put in a tremendous amount of hard work and expertise into resolving the issues at hand. I would also like to take this opportunity to inform you that we are greatly interested

Overall, the deliverable was well organized and my experience with the project team was good. In particular, I appreciated how they responded when I requested additional information and the Japanese version.

The IMARC team were extremely professional and very cooperative. The team were also extremely flexible in making changes and modifications wherever required. The entire experience right from project kick-off to after sales support was fruitful and smooth.

I’d like to express my gratitude for the work you accomplished with the industry report. The way you responded to the requirements and delivered under tight timelines shows your expertise, exceptional work ethic and commitment to your customer’s success. The entire team and company are incredibly thankful for your dedication. Once again, thank you

The market reports from IMARC have been instrumental in guiding our business strategies. We found the reports comprehensive and data-driven, which helped us make informed decisions. The detailed insights and actionable data have consistently provided us with a competitive edge in a rapidly changing alcohol market.

One of the best things about IMARC is their flexibility and predisposition to tailor the reports and adapt to our needs. They are not just great in their researching and consulting solutions, but their service is unparallelled. We’ve worked with them a couple of times and we will keep working with them in future projects.

We recently commissioned multiple market research reports from IMARC, and the insights we received were invaluable. The depth of analysis, accuracy of data, and actionable recommendations have greatly enhanced our strategic decision-making.

The market estimates provided by your team were pretty much in line with what we were theorizing internally. Really appreciate the work on this.

The sale account manager and the service was excellent. The data and market trends gathered from the report was insightful and really assisted while planning future product and growth strategies.

The report is excellent and has good amount of data and our team is extremely happy with the information provided.

Thank you very much for your cooperation and post purchase support. We were really happy with the final deliverable, and the takeaways from the report.